{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:34:28Z","timestamp":1792661668578,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870304"],"award-info":[{"award-number":["81870304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201508500057"],"award-info":[{"award-number":["201508500057"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["GR1517\/14-1"],"award-info":[{"award-number":["GR1517\/14-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.kint.2018.10.022","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T07:02:06Z","timestamp":1548313326000},"page":"611-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factors"],"prefix":"10.1016","volume":"95","author":[{"given":"Jun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Koerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Basler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Kirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5423-6399","authenticated-orcid":false,"given":"Marcus","family":"Groettrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2018.10.022_bib1","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1097\/TP.0000000000001756","article-title":"Rapid discontinuation of prednisone in kidney transplant recipients: 15-year outcomes from the University of Minnesota","volume":"101","author":"Serrano","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.022_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nri1702","article-title":"Antibody-mediated organ-allograft rejection","volume":"5","author":"Colvin","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2018.10.022_bib3","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1089\/ars.2014.5892","article-title":"Review of bortezomib treatment of antibody-mediated rejection in renal transplantation","volume":"21","author":"Ejaz","year":"2014","journal-title":"Antioxidants Redox Signaling"},{"key":"10.1016\/j.kint.2018.10.022_bib4","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/TP.0b013e318190af83","article-title":"Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection","volume":"86","author":"Everly","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.022_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-6143.2008.02461.x","article-title":"Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production","volume":"9","author":"Perry","year":"2009","journal-title":"Am J Transplantation"},{"key":"10.1016\/j.kint.2018.10.022_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/TP.0b013e3181c6ff8d","article-title":"Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection","volume":"89","author":"Walsh","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.022_bib7","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1093\/ndt\/gfq230","article-title":"Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat","volume":"25","author":"Vogelbacher","year":"2010","journal-title":"Nephrol Dialysis Transplantation"},{"key":"10.1016\/j.kint.2018.10.022_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cell.2011.12.030","article-title":"Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity","volume":"148","author":"Huber","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.kint.2018.10.022_bib9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/cr.2016.86","article-title":"The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death","volume":"26","author":"Livneh","year":"2016","journal-title":"Cell Res"},{"key":"10.1016\/j.kint.2018.10.022_bib10","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1002\/anie.200501724","article-title":"The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle","volume":"44","author":"Hershko","year":"2005","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.kint.2018.10.022_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-pharmtox-010814-124727","article-title":"Structure-driven developments of 26S proteasome inhibitors","volume":"56","author":"Sledz","year":"2016","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"10.1016\/j.kint.2018.10.022_bib12","first-page":"1","article-title":"Safety of proteasome inhibitors for treatment of multiple myeloma","volume":"16","author":"Schlafer","year":"2017","journal-title":"Exp Opin Drug Safety"},{"key":"10.1016\/j.kint.2018.10.022_bib13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/TP.0b013e318257acf6","article-title":"Prospective evaluation of the toxicity profile of proteasome inhibitor-based therapy in renal transplant candidates and recipients","volume":"94","author":"Schmidt","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2018.10.022_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nri2687","article-title":"Proteasomes in immune cells: more than peptide producers?","volume":"10","author":"Groettrup","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.kint.2018.10.022_bib15","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4049\/jimmunol.0903182","article-title":"Prevention of experimental colitis by a selective inhibitor of the immunoproteasome","volume":"185","author":"Basler","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.022_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/emmm.201303543","article-title":"Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis","volume":"6","author":"Basler","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.kint.2018.10.022_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/art.33333","article-title":"Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells","volume":"64","author":"Ichikawa","year":"2012","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.kint.2018.10.022_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneuroim.2017.08.005","article-title":"ONX-0914, a selective inhibitor of immunoproteasome, ameliorates experimental autoimmune myasthenia gravis by modulating humoral response","volume":"311","author":"Liu","year":"2017","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.kint.2018.10.022_bib19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm.1978","article-title":"A\u00a0selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis","volume":"15","author":"Muchamuel","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2018.10.022_bib20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-2249.2012.04578.x","article-title":"Prophylactic and therapeutic efficacies of a selective inhibitor of the immunoproteasome for Hashimoto's thyroiditis, but not for Graves\u2019 hyperthyroidism, in mice","volume":"168","author":"Nagayama","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.kint.2018.10.022_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.kint.2017.09.023","article-title":"Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation","volume":"93","author":"Li","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2018.10.022_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-1-61779-474-2_27","article-title":"Immunoproteasome-specific inhibitors and their application","volume":"832","author":"Basler","year":"2012","journal-title":"Meth Mol Biol"},{"key":"10.1016\/j.kint.2018.10.022_bib23","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.4049\/jimmunol.1201183","article-title":"Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation","volume":"189","author":"Kalim","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.022_bib24","doi-asserted-by":"crossref","first-page":"19434","DOI":"10.1038\/srep19434","article-title":"Inhibiting the immunoproteasome exacerbates the pathogenesis of systemic Candida albicans infection in mice","volume":"6","author":"Mundt","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.kint.2018.10.022_bib25","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1073\/pnas.77.7.4251","article-title":"Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells","volume":"77","author":"Kavathas","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2018.10.022_bib26","doi-asserted-by":"crossref","unstructured":"Schmidtke G, Schregle R, Alvarez G, et\u00a0al. The 20S immunoproteasome and constitutive proteasome bind with the same affinity to PA28\u03b1\u03b2 and equally degrade FAT10 [e-pub ahead of print]. Mol Immunol. https:\/\/doi.org\/10.1016\/j.molimm.2017.11.030. Accessed November 30,\u00a02018.","DOI":"10.1016\/j.molimm.2017.11.030"},{"key":"10.1016\/j.kint.2018.10.022_bib27","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: from stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.kint.2018.10.022_bib28","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nm1763","article-title":"The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis","volume":"14","author":"Neubert","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2018.10.022_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cyto.a.22355","article-title":"Tracking plasma cell differentiation and survival","volume":"85","author":"Roth","year":"2014","journal-title":"Cytometry A"},{"key":"10.1016\/j.kint.2018.10.022_bib30","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/eji.201444871","article-title":"Finding a home for plasma cells--a niche to survive","volume":"44","author":"Tellier","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.kint.2018.10.022_bib31","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.4049\/jimmunol.1001517","article-title":"Reduced immunoproteasome formation and accumulation of immunoproteasomal precursors in the brains of lymphocytic choriomeningitis virus-infected mice","volume":"185","author":"Kremer","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.022_bib32","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/eji.1830270520","article-title":"Molecular cloning of the mouse proteasome subunits MC14 and MECL-1: reciprocally regulated tissue expression of interferon-\u03b3- modulated proteasome subunits","volume":"27","author":"Stohwasser","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.kint.2018.10.022_bib33","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1182\/blood-2009-05-223677","article-title":"Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome","volume":"114","author":"Parlati","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.kint.2018.10.022_bib34","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1189\/jlb.1011497","article-title":"Pivotal advance: protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors","volume":"92","author":"Cenci","year":"2012","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.kint.2018.10.022_bib35","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrd3976","article-title":"Targeting the unfolded protein response in disease","volume":"12","author":"Hetz","year":"2013","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.kint.2018.10.022_bib36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/mi.2015.38","article-title":"Long-lived plasma cells are generated in mucosal immune responses and contribute to the bone marrow plasma cell pool in mice","volume":"9","author":"Lemke","year":"2016","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.kint.2018.10.022_bib37","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.4049\/jimmunol.169.3.1277","article-title":"Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response","volume":"169","author":"Hauser","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.022_bib38","doi-asserted-by":"crossref","first-page":"50873","DOI":"10.18632\/oncotarget.15141","article-title":"Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice","volume":"8","author":"Koerner","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.kint.2018.10.022_bib39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/eji.201545578","article-title":"Inhibition and deficiency of the immunoproteasome subunit LMP7 attenuates LCMV-induced meningitis","volume":"46","author":"Mundt","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.kint.2018.10.022_bib40","doi-asserted-by":"crossref","first-page":"50447","DOI":"10.18632\/oncotarget.14579","article-title":"Prevention of colitis-associated cancer by selective targeting of immunoproteasome subunit LMP7","volume":"8","author":"Vachharajani","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.kint.2018.10.022_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10787-011-0104-6","article-title":"Targeting leukocyte migration and adhesion in Crohn\u2019s disease and ulcerative colitis","volume":"20","author":"Thomas","year":"2012","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.kint.2018.10.022_bib42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4049\/jimmunol.180.1.361","article-title":"Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice","volume":"180","author":"DiLillo","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.kint.2018.10.022_bib43","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/ajt.12674","article-title":"Characterization of transfusion-elicited acute antibody-mediated rejection in a rat model of kidney transplantation","volume":"14","author":"Huang","year":"2014","journal-title":"Am J Transplantation"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818308238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818308238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:52:53Z","timestamp":1758761573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818308238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0085253818308238"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2018.10.022","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunoproteasome inhibition induces plasma cell apoptosis and preserves kidney allografts by activating the unfolded protein response and suppressing plasma cell survival factors","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2018.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}